Events & News

Upcoming events

RPA 2025 Annual Meeting

Apr 3-6

Conference

RPA 2025 Annual Meeting

ANNA National Symposium

May 1-4

Conference

ANNA National Symposium

NTI 2025 New Orleans

May 18-21

Conference

NTI 2025 New Orleans

NBLU 2025

Aug 12-16

Conference

NBLU 2025

Aug 18-20

Conference

RETHINK Conference

AHCA/NCAL Annual Convention

Oct 12-15

Conference

AHCA/NCAL Annual Convention

Becker’s 13th Annual CEO + CFO Roundtable

Nov 3-6

Webinar

Becker’s 13th Annual CEO + CFO Roundtable

ASN Kidney Week 2025

Nov 5-9

Conference

ASN Kidney Week

Catch up on past events

Press highlights

"[Auxiliary care] is growing in demand as acuity is rising in facilities, patients tend to be less stable, and hospitals are trying to minimize lengths of stay."

Provider Magazine

"The home dialysis developer’s CEO discusses leadership, leaping before you look and making medtech for the home and hospital."

Medical Design & Outsourcing

"Nearly 200 comments supportive of Tablo as a significant innovative improvement over the existing technology were submitted."

"But the winners and honorable mentions span a gamut of issues related to medical challenges, including a new device that makes dialysis less of a burden."

FT ranking: The Americas’ Fastest-Growing Companies 2023

The FT is pleased to announce this fourth annual ranking of the fastest growing companies in the Americas….#10 Outset Medical

Man shares how home dialysis changed his life

While the treatment is lifesaving, it is also life-changing, forcing patients to fit their lives into their dialysis schedules.

Global Excellence Awards - Full Winners Listing

« Previous 1 2 3 … 6 7 8 9 10 … 15 16 17 Next »

See all press highlights

1883-v1 (v1.0)

INDICATIONS FOR USE:

The Tablo^® Hemodialysis System and TabloCart™ is indicated for use in patients with acute and/or chronic renal failure, with or without ultrafiltration, in an acute or chronic care facility. Treatments must be administered under physician’s prescription and observed by a trained individual who is considered competent in the use of the device. The Tablo Hemodialysis System is also indicated for use in the home. Treatment types available include Intermittent Hemodialysis (IHD), Sustained Low Efficiency Dialysis (SLED/ SLEDD), Prolonged Intermittent Renal Replacement Therapy (PIRRT), and Isolated Ultrafiltration.

This device is not indicated for continuous renal replacement therapy (CRRT) and is cleared for use for up to 24 hours. The dialysate generated by this device is not sterile and should not be used for intravenous (IV) infusion.

2214-v2

Tablo

Clinical evidence

Patients

Kidney health 101

Request more info

Why home dialysis

Healthcare providers

Skilled Nursing Facilities

Resources

Customer resources

Press highlights

About

Stay connected

Stay connected

© 2024 Outset Medical, Inc. All rights reserved. Outset, Tablo, TabloCart, MyTablo, TabloHub, and Better Begins Now are trademarks of our company.

Consumer Health Data Privacy

Do not sell/share my personal info

Important Safety Information